Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study

NCT06534424 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

152

Enrollment

OTHER

Sponsor class

Conditions

BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome

Interventions

OTHER: Best Practice
PROCEDURE: Biospecimen Collection
OTHER: Counseling
PROCEDURE: Discussion
PROCEDURE: Genotyping
PROCEDURE: Molecular Risk Assessment
OTHER: Questionnaire Administration

Sponsor

Ohio State University Comprehensive Cancer Center